N/A N=3 Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study
Spina Bifida · Myelomeningocele · Neural Tube Defects
Primary: Maternal Adverse Events — 2 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=6,781 Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester
Congenital Heart Defects
Primary: Sensitivity of Color Doppler Examination to Detect Major Heart Defects During the Second Trimester of Pregnancy — 39; 9 fetuses
N/A N=90 Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy
Fetal Heart Echocardiography by Five Dimensional Ultrasound
Primary: Number of Satisfactory Fetal Echocardiography Views by Two-Dimensional Ultrasound — 8.7 Number of satisfactory views
N/A N=1,097 Prenatal Genetic Diagnosis by Genomic Sequencing
Fetal Structural Anomalies
Primary: Number of Participants Who Had Reportable Variants — 114; 22 Participants
N/A N=206 Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial
Uncomplicated Pregnancy · Abnormal Fetal Growth or Fluid
Primary: Number of Participants With Fetal Growth Restriction — 2; 8 Participants
Phase 2 N=5 'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial
Hernia · Hernia, Diaphragmatic · Hernia, DIaphragmatic, Congenital
Primary: Proportion of Neonate Survival at Discharge From Hospital — 1; 3 Participants
N/A N=90 Automated Fetal Femur Length Measurement by Five-Dimensional Ultrasound
Automated Fetal Femur Length Measurement by Five-Dimensional Ultrasound
Primary: Gestational Age Calculated by Accurate Dates of the Last Menstrual Period — 35.6 weeks
Phase 1 N=22 PED NEONAT 20-000599 Fetal Body Composition
IUGR · Gestational Diabetes · Pregnancy Related
Primary: Maternal Visceral Adipose Tissue Volume — 97593; 169626; 96787 mm3
N/A N=813 Third Trimester Screening of Fetal Growth Restriction
Fetal Growth Retardation · Fetal; Slow Growth
Primary: Rate of Small for Gestational Age at Birth Identified Antenatally — 28; 46 Participants
N/A N=39 Fetal and Neonatal Magnetophysiology
Fetal Arrhythmia · Abnormality in Fetal Heart Rate or Rhythm · Long QT Syndrome
Primary: Percentage of Subjects Experiencing Symptoms — 0; 0 Participants
N/A N=47 Antecedents of Obesity: Fetal Measures of Adiposity
Obesity
Primary: Infant Adiposity at 24-72 Hours Following Birth — 11 Percentage of total body weight
N/A N=128 Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O)
Obesity
Primary: Completion Rate for First Trimester Scans — 66 percent
N/A N=50 The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage
Circulating Cell Free Fetal DNA · Intrauterine Fetal Demise · Miscarriage
Primary: The Presence or Absence of Cell Free Fetal DNA in Maternal Blood in the Setting of a Failed Pregnancy. — 50 percentage of participants
N/A N=165 Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy
Congenital Heart Disease
Primary: To Evaluate the Incidence of the Pre-proendothelin SNP at Nucleotide 5665 — 10 participants
N/A N=150 Pannus Assistance Needed for Obstetric Ultrasound Studies
Obesity Complicating Childbirth · Fetal Anomaly
Primary: Completion Rate of 16 Prespecified Views — 19; 24 Participants
Early Phase 1 N=3 Placental Lesions in Fetal Growth Restrictions
Fetal Growth Retardation
Primary: Number of Participants for Which Intervillous Placental Blood is Detected — 3 Participants
N/A N=135 Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion
Medical; Abortion, Fetus
Primary: Cervicovaginal Fetal Fibronectin Level — 39.4 nanogram per milliliter
N/A N=30 Maternal Fetal Device Performance Singleton
Pregnancy
Primary: Success Rate Calculated Based on Collection of Fetal Heart Rate Data From Investigational Devices on Subjects Enrolled in Each Gestational Age Group — 85.01; 92.27…
N/A N=19 Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment
Pregnancy · Drug Abuse
Primary: Fetal Heart Rate — 142.34 beats per minute
N/A N=357 Hemangioma Associated With High Rates of Morbidity
Hemangioma
Primary: MRI/MRA of Head/Neck/Chest. — 357 participants
N/A N=60 Predicting Placental Pathologies by Ultrasound Imaging
Intrauterine Growth Restriction · Villitis · IUGR
Primary: Number of Participants With Uterine Artery Indices Completed — 13; 3 Participants
N/A N=80 The Role of Umbilical Cord Thickness in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus
Gestational Diabetes
Primary: The Number of Participants Who Were Diagnosed With Fetal Macrosomia (Birth Weight) — 17; 0 participants
N/A N=5 Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery
Intrauterine Growth Retardation
Primary: Survival — 100; 100 percentage of AGA babies who survived
N/A N=183 Management of Myelomeningocele Study (MOMS)
Meningomyelocele · Spinal Dysraphism
Primary: Infant Death or Need for Ventricular Shunt by 1 Year of Life — 66; 90 Participants
N/A N=21 Delayed Cord Clamping for Congenital Diaphragmatic Hernia
Congenital Diaphragmatic Hernia
Primary: Proportion of Infants Who Are Intubated Prior to Umbilical Cord Clamping — 17 Participants
N/A N=11,108 Fetal ST Segment and T Wave Analysis in Labor
Pregnancy · Obstetric Labor · Parturition
Primary: Number of Participants With Primary Composite Outcome — 52; 40 Participants — p=0.20
Phase 3 N=36 In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)
Hemostasis
Primary: Clot Degradation at 24 Hours Post-operatively — 0.65; 0.88; 0.78; 0.46 microns per hour
N/A N=534 Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
Pregnancy
Primary: Percentage of Infants With Major Birth Defects in Pregnancies Ending With Live-born Infants — 9.4; 3.5 percentage of participants
N/A N=220 PGT-A Versus Blastocyst Morphology Selection
Pregnancy
Primary: The Percentage of Patients With a Live Birth — 45; 65 Participants